Common diabetes drug tested to prevent uterine problems in breast cancer treatment
NCT ID NCT07145827
Summary
This study tested whether adding the diabetes medication metformin to tamoxifen treatment could reduce thickening of the uterine lining in postmenopausal breast cancer patients. Researchers compared 60 women taking tamoxifen plus metformin against those taking tamoxifen plus a placebo pill over 12 months. The goal was to see if metformin could help prevent uterine side effects while maintaining breast cancer protection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baghdad Medical City / Department of Oncology
Baghdad, Baghdad Governorate, 10045, Iraq
Conditions
Explore the condition pages connected to this study.